Primary myelofibrosis and Eosinophil count increased

Summary:

Eosinophil count increased is found among people with Primary myelofibrosis, especially for people who are male, 60+ old.

The study analyzes which people have Eosinophil count increased with Primary myelofibrosis. It is created by eHealthMe based on reports of 32 people who have Primary myelofibrosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Primary myelofibrosis?

Primary myelofibrosis (primary disorder of the bone marrow) is found to be associated with 322 drugs and 841 conditions by eHealthMe. Check the latest studies of Primary myelofibrosis.

What is Eosinophil count increased?

Eosinophil count increased is found to be associated with 768 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Eosinophil count increased.



On Aug, 01, 2026

32 people who have Primary Myelofibrosis and Eosinophil Count Increased are studied.

Would you have Eosinophil count increased when you have Primary myelofibrosis?

Gender of people who have Primary Myelofibrosis and experienced Eosinophil Count Increased *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Primary Myelofibrosis and experienced Eosinophil Count Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 4 people, 12.50%
  2. Iron Overload: 4 people, 12.50%
  3. Blood Uric Acid Increased: 3 people, 9.38%
  4. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 6.25%
  5. Arterial Injury: 2 people, 6.25%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.25%
  7. Bacterial Infection: 2 people, 6.25%
  8. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 6.25%
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 6.25%
  10. Thyroid Diseases: 2 people, 6.25%

Common drugs taken by these people *:

  1. Vidaza: 4 people, 12.50%
  2. Exjade: 4 people, 12.50%
  3. Hydrea: 4 people, 12.50%
  4. Pantoprazole: 3 people, 9.38%
  5. Zolpidem: 2 people, 6.25%
  6. Jakafi: 2 people, 6.25%
  7. Januvia: 2 people, 6.25%
  8. Lanoxin: 2 people, 6.25%
  9. Lantus: 2 people, 6.25%
  10. Adcal: 2 people, 6.25%

Common symptoms for these people *:

  1. White Blood Cell Count Increased: 25 people, 78.12%
  2. Haemoglobin Decreased: 21 people, 65.62%
  3. Basophil Count Increased: 16 people, 50.00%
  4. Haematocrit Decreased: 15 people, 46.88%
  5. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 15 people, 46.88%
  6. Monocyte Count Increased: 15 people, 46.88%
  7. Red Blood Cell Count Decreased: 14 people, 43.75%
  8. Thrombocytopenia (decrease of platelets in blood): 11 people, 34.38%
  9. Lymphocyte Count Increased: 8 people, 25.00%
  10. Neutrophil Percentage Increased: 8 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eosinophil count increased?

- Check whether Eosinophil count increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Eosinophil count increased:

All the conditions that are associated with Eosinophil count increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eosinophil count increased and Primary myelofibrosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: